Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-03 Watanabe Todd Franklin President and CEO Grant or award · Stock Option (Right to Buy) +188,100 188,100
2022-03-03 Burnett Patrick Grant or award +17,800 44,050
2022-03-03 Burnett Patrick Grant or award · Stock Option (Right to Buy) +47,100 47,100
2022-03-03 Matsuda Masaru SVP and General Counsel Grant or award +13,300 13,300
2022-03-03 Matsuda Masaru SVP and General Counsel Grant or award · Stock Option (Right to Buy) +35,300 35,300
2022-03-03 Lock Kenneth A. Chief Commercial Officer Grant or award +13,300 45,034
2022-03-03 Lock Kenneth A. Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +35,300 35,300
2022-03-03 Burrows Scott L Chief Financial Officer Grant or award +13,300 35,559
2022-03-03 Burrows Scott L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +35,300 35,300
2022-03-03 Turney Patricia A. SVP, Operations Grant or award +13,300 32,136
2022-03-03 Turney Patricia A. SVP, Operations Grant or award · Stock Option (Right to Buy) +35,300 35,300
2022-03-03 OSBORNE DAVID W Chief Technical Officer Grant or award +13,300 260,282
2022-03-03 OSBORNE DAVID W Chief Technical Officer Grant or award · Stock Option (Right to Buy) +35,300 35,300
2022-03-03 Moore Matthew Richard SVP and Chief Business Officer Grant or award +13,300 13,300
2022-03-03 Moore Matthew Richard SVP and Chief Business Officer Grant or award · Stock Option (Right to Buy) +35,300 35,300
2022-03-01 Watanabe Todd Franklin President and CEO Sale −2,153 $17.75 $38K 592,626
2022-03-01 OSBORNE DAVID W Chief Technical Officer Sale −775 $17.75 $14K 246,982
2022-03-01 Burrows Scott L Chief Financial Officer Sale −420 $17.75 $7K 22,259
2022-03-01 Turney Patricia A. SVP, Operations Sale −936 $17.75 $17K 18,836
2022-03-01 Lock Kenneth A. Chief Commercial Officer Sale −935 $17.75 $17K 31,734

Page 32 of 35 · 689 trades